Human Genome Epidemiology Literature Finder
Records 1 - 18 (of 18 Records) |
Query Trace: Leukemia and CD19[original query] |
---|
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood 2009 Dec 114 (26): 5352-61. Tang Jih-Luh, Hou Hsin-An, Chen Chien-Yuan, Liu Chieh-Yu, Chou Wen-Chien, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Lin Liang-In, Tien Hwei-Fa |
[Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype]. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2013 Dec 21 (6): 1385-9. Liu Yan-Rong, Lai Yue-Yun, Chang Yan, Ruan Guo-Rui, Qin Ya-Zhen, Wang Ya-Zhe, Zhu Hong-Hu, Shi Hong-Xia, Jiang Bin, Jiang Hao, Jiang Qian, Hao Le, Li Jin-L |
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment. Leukemia research 2015 Aug 39 (8): 840-5. Morabito Fortunato, Cutrona Giovanna, Mosca Laura, D'Anca Marianna, Matis Serena, Gentile Massimo, Vigna Ernesto, Colombo Monica, Recchia Anna Grazia, Bossio Sabrina, De Stefano Laura, Maura Francesco, Manzoni Martina, Ilariucci Fiorella, Consoli Ugo, Vincelli Iolanda, Musolino Caterina, Cortelezzi Agostino, Molica Stefano, Ferrarini Manlio, Neri Antoni |
[Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016 Aug 37 (8): 676-81. Zhao J X, Chen X H, Li J L, Pan J, Tan Y H, Xu Z F, Ren F G, Zhang Y F, Xu J, Li M Q, Li J, Zhang N, Chang J M, Wang X J, Wang H |
[Analysis of Clinical Characteristics in 31 Acute Myeloid Leukemia Patients with Chromosome 21 Aberrations]. Zhongguo shi yan xue ye xue za zhi 2017 8 25 (4): 992-997. Yu Hai-Zhi, Cheng Zhao, Xie Si-Si, Yi Yi-Fang, Peng Hong-Li |
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia. Journal of hematology & oncology 2017 Apr 10 (1): 83. Quijada-Álamo Miguel, Hernández-Sánchez María, Robledo Cristina, Hernández-Sánchez Jesús-María, Benito Rocío, Montaño Adrián, Rodríguez-Vicente Ana E, Quwaider Dalia, Martín Ana-África, García-Álvarez María, Vidal-Manceñido María Jesús, Ferrer-Garrido Gonzalo, Delgado-Beltrán María-Pilar, Galende Josefina, Rodríguez Juan-Nicolás, Martín-Núñez Guillermo, Alonso José-María, García de Coca Alfonso, Queizán José A, Sierra Magdalena, Aguilar Carlos, Kohlmann Alexander, Hernández José-Ángel, González Marcos, Hernández-Rivas Jesús-Mar |
miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations. Molecular and cellular probes 2019 Aug 101436. Li Yan, Mao Min, Liu Hong, Wang Xiaomin, Kou Zhen, Nie Yuling, Wang Yichun, Wang Zengsheng, Huang Qin, Lang Tao, Gu Zailinuer, An Li, Zhang Xiaoyan, Fu L |
The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies. Cytotherapy 2019 May . Cao Jun-Xia, Gao Wei-Jian, You Jia, Wu Li-Hua, Liu Jin-Long, Wang Zheng- |
[Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia]. Zhongguo shi yan xue ye xue za zhi 2020 2 28 (1): 34-39. Wang Fei, Xu Wei, Gu Wei-Ying, Li Jian-Yo |
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement. Blood advances 2020 1 4 (1): 106-111. Nardi Valentina, Ku Nora, Frigault Matthew J, Dubuc Adrian M, Tsai Harrison Kwei, Amrein Philip C, Hobbs Gabriela S, Brunner Andrew M, Narayan Rupa, Burke Meghan E, Foster Julia, Dal Cin Paola, Maus Marcela V, Fathi Amir T, Hock Han |
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia. Cancer immunology, immunotherapy : CII 2021 8 71 (3): 689-703. Zhang Xian, Yang Junfang, Li Jingjing, Li Wenqian, Song Dan, Lu Xin-An, Wu Fei, Li Jianqiang, Chen Dandan, Li Xiangqun, Xu Zhongwei, Liu Shuqiang, Li Ziyu, Ying Kui, Lu Peih |
[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2021 7 42 (5): 396-401. Du Y Y, Lyu K K, Xu M M, Yao W Q, Kang H Z, Han Y, Tang X W, Ma X, Wu X J, He X F, Wu D P, Liu Y |
Clinical significance of CD34CD117/CD34CD117 myeloblast-associated gene expression in t(8;21) acute myeloid leukemia. Frontiers of medicine 2021 3 15 (4): 608-620. Li Xueping, Dai Yuting, Chen Bing, Huang Jinyan, Chen Saijuan, Jiang |
T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCR??+/CD19+ Depletion Platforms. Frontiers in oncology 2022 7 12 884397. Gonzalez-Vicent Marta, Molina Blanca, Lopez Ivan, Zubicaray Josune, Ruiz Julia, Vicario Jose Luis, Sebastián Elena, Iriondo June, Castillo Ana, Abad Lorea, Ramirez Manuel, Sevilla Julian, Diaz Miguel |
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nature medicine 2022 3 28 (4): 713-723. Smith Melody, Dai Anqi, Ghilardi Guido, Amelsberg Kimberly V, Devlin Sean M, Pajarillo Raymone, Slingerland John B, Beghi Silvia, Herrera Pamela S, Giardina Paul, Clurman Annelie, Dwomoh Emmanuel, Armijo Gabriel, Gomes Antonio L C, Littmann Eric R, Schluter Jonas, Fontana Emily, Taur Ying, Park Jae H, Palomba Maria Lia, Halton Elizabeth, Ruiz Josel, Jain Tania, Pennisi Martina, Afuye Aishat Olaide, Perales Miguel-Angel, Freyer Craig W, Garfall Alfred, Gier Shannon, Nasta Sunita, Landsburg Daniel, Gerson James, Svoboda Jakub, Cross Justin, Chong Elise A, Giralt Sergio, Gill Saar I, Riviere Isabelle, Porter David L, Schuster Stephen J, Sadelain Michel, Frey Noelle, Brentjens Renier J, June Carl H, Pamer Eric G, Peled Jonathan U, Facciabene Andrea, van den Brink Marcel R M, Ruella Mar |
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 10 29 (4): 742-753. Aldoss Ibrahim, Khaled Samer K, Wang Xiuli, Palmer Joycelynne, Wang Yan, Wagner Jamie R, Clark Mary C, Simpson Jennifer, Paul Jinny, Vyas Vibhuti, Chien Sheng-Hsuan, Stein Anthony, Pullarkat Vinod, Salhotra Amandeep, Al Malki Monzr M, Aribi Ahmed, Sandhu Karamjeet, Thomas Sandra H, Budde Lihua E, Marcucci Guido, Brown Christine E, Forman Stephen |
TCR??/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis. Blood 2023 9 . Pietro Merli, Mattia Algeri, Federica Galaverna, Valentina Bertaina, Barbarella Lucarelli, Emilia Boccieri, Marco Becilli, Francesco Quagliarella, Chiara Rosignoli, Simone Biagini, Elia Girolami, Antonella Meschini, Giovanna Del Principe, Raffaella Sborgia, Maria Luigia Catanoso, Roberto Carta, Luisa Strocchio, Rita Maria Pinto, Barbara Buldini, Michela Falco, Raffaella Meazza, Daniela Pende, Marco Andreani, Giuseppina Li Pira, Daria Pagliara, Franco Locatel |
A comprehensive analysis of cytogenetics, molecular profile, and survival among pediatric acute myeloid leukemia: a prospective study from a tertiary referral center. American journal of blood research 2023 2 12 (6): 177-189. Meena Jagdish Prasad, Makkar Harshita, Gupta Aditya Kumar, Bakhshi Sameer, Gupta Ritu, Thakral Deepshi, Chopra Anita, Tanwar Pranay, Upadhyay Ashish Datt, Pathak Nivedita, Seth Rach |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: